补充Candida介质增强免疫反应并调节SARS-CoV-2疫苗接种小鼠的肠道微生物群

Renan E A Piraine1,2, Neida L Conrad1, Vitória S Gonçalves1

  • 1Microbiology Laboratory, Technological Development Center, Federal University of Pelotas, Pelotas 96010-610, RS, Brazil.

PubMed
概括

非Saccharomyces酵母Candida中间体显示出益生菌潜力,增强免疫反应和针对SARS-CoV-2接种疫苗的小鼠的抗体产生. 这种酵母可以作为一种新的益生菌和疫苗辅助剂.